These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 21506052

  • 1. Candida prophylaxis and therapy in the ICU.
    Echeverria PM, Kett DH, Azoulay E.
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 3. Candidemia in children.
    Zaoutis T.
    Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
    [Abstract] [Full Text] [Related]

  • 4. Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines.
    Tsuruta R, Mizuno H, Kaneko T, Oda Y, Kaneda K, Fujita M, Inoue T, Kasaoka S, Maekawa T.
    Ann Pharmacother; 2007 Jul; 41(7):1137-43. PubMed ID: 17535843
    [Abstract] [Full Text] [Related]

  • 5. Antifungals in the ICU.
    Playford EG, Eggimann P, Calandra T.
    Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
    [Abstract] [Full Text] [Related]

  • 6. Candidemia in the critically ill patient.
    Picazo JJ, González-Romo F, Candel FJ.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
    [Abstract] [Full Text] [Related]

  • 7. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
    Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM.
    Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
    [Abstract] [Full Text] [Related]

  • 8. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
    Parkins MD, Sabuda DM, Elsayed S, Laupland KB.
    J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
    [Abstract] [Full Text] [Related]

  • 9. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C.
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [Abstract] [Full Text] [Related]

  • 10. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS, Swoboda SM, Shields CE, Colantuoni EA, Fothergill AW, Merz WG, Lipsett PA, Hendrix CW.
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [Abstract] [Full Text] [Related]

  • 11. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE.
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [Abstract] [Full Text] [Related]

  • 12. Optimizing therapy for Candida infections.
    Playford EG, Sorrell TC.
    Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
    [Abstract] [Full Text] [Related]

  • 13. Current treatment strategies for disseminated candidiasis.
    Spellberg BJ, Filler SG, Edwards JE.
    Clin Infect Dis; 2006 Jan 15; 42(2):244-51. PubMed ID: 16355336
    [Abstract] [Full Text] [Related]

  • 14. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
    Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA.
    Int J Antimicrob Agents; 2009 Sep 15; 34(3):205-9. PubMed ID: 19409759
    [Abstract] [Full Text] [Related]

  • 15. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.
    Crit Care Med; 2008 Jul 15; 36(7):2034-9. PubMed ID: 18552700
    [Abstract] [Full Text] [Related]

  • 16. Is Candida really a threat in the ICU?
    Blot S, Dimopoulos G, Rello J, Vogelaers D.
    Curr Opin Crit Care; 2008 Oct 15; 14(5):600-4. PubMed ID: 18787456
    [Abstract] [Full Text] [Related]

  • 17. [Invasive candidiasis in critically ill adult patient].
    Tobar A E, Silva O F, Olivares C R, Gaete G P, Luppi N M.
    Rev Chilena Infectol; 2011 Feb 15; 28(1):41-9. PubMed ID: 21526285
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

  • 19. Antifungal therapy for neonatal candidiasis.
    Zaoutis T, Walsh TJ.
    Curr Opin Infect Dis; 2007 Dec 15; 20(6):592-7. PubMed ID: 17975409
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
    Davis SL, Vazquez JA, McKinnon PS.
    Ann Pharmacother; 2007 Apr 15; 41(4):568-73. PubMed ID: 17374623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.